Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Invion reports interim data from phase II trial of oral INV-102 in smoking cessation

Jan. 21, 2015

Evotec and C4X Discovery collaborate to discover OX1 receptor inhibitors for addiction

Jan. 19, 2015

Dr. Reddy's completes acquisition of Habitrol

Dec. 24, 2014

Temple University prepares and tests novel glutamate uptake modulators

Dec. 23, 2014

Noribogaine HCl safe and well tolerated in healthy volunteers

Dec. 12, 2014

Researchers present novel radiomitigating compounds

Nov. 28, 2014

PRO-028 and PRO-027: novel NAC analogues for cocaine addiction

Nov. 26, 2014

RGFP-966, an epigenetic HDAC3 inhibitor, tested in a rat cocaine-abuse model

Nov. 17, 2014

Eisai and Arena report phase II data for lorcaserin in smoking cessation

Nov. 4, 2014

Orexo applies to FDA to expand Zubsolv label to include initiation of opioid dependence therapy

Oct. 13, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...